norgestrel and Cardiovascular Diseases

norgestrel has been researched along with Cardiovascular Diseases in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-199014 (58.33)18.7374
1990's9 (37.50)18.2507
2000's0 (0.00)29.6817
2010's1 (4.17)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weisberg, E1
Goldzieher, JW1
Christie, T1
Guillebaud, J1
Haspels, AA1
Punnonen, R; Rauramo, L; Vilska, S1
Kay, CR1
Niththyananthan, R; Wynn, V1
Meade, TW1
Greenberg, G; Meade, TW; Thompson, SG1
Taskinen, MR1
Sobel, NB1
Crook, D; Godsland, IF; Lees, B; Stevenson, JC; Whitehead, MI1
Oyelola, OO1
Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D1
Al-Qattan, N; Omu, AE1
Barnes, JF; Calder, A; Ekevall, K; Farish, E; Fletcher, CD; Hart, DM1
Andersen, LF; Christiansen, E; Jespersen, J; Madsbad, S; Petersen, KR; Skouby, SO1
Larsson-Cohn, U; Wallentin, L; Zador, G1
Baz, CR1
Dubnitskaia, LV; Korsakov, SG; Manuilova, IA1
Keller, PJ1
Hoppe, G1

Reviews

2 review(s) available for norgestrel and Cardiovascular Diseases

ArticleYear
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
    Obstetrics and gynecology clinics of North America, 1994, Volume: 21, Issue:2

    Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship

1994
[Hormonal contraception using depot preparations].
    Therapeutische Umschau. Revue therapeutique, 1986, Volume: 43, Issue:5

    Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk

1986

Trials

7 trial(s) available for norgestrel and Cardiovascular Diseases

ArticleYear
The 150/30 formulation. Experience in the United Kingdom.
    The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl

    Topics: Adult; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Risk; Smoking; Stereoisomerism; United Kingdom

1983
Clinical experience with a low-dose contraceptive agent. European studies.
    The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl

    Topics: Adolescent; Adult; Amenorrhea; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy; Stereoisomerism

1983
Oral versus transdermal hormone replacement therapy.
    International journal of fertility and menopausal studies, 1993, Volume: 38 Suppl 1

    Topics: Administration, Cutaneous; Administration, Oral; Blood Glucose; Bone Density; Cardiovascular Diseases; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin; Lipoproteins; Longitudinal Studies; Menopause; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides; White People

1993
Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
    Contraception, 1993, Volume: 47, Issue:5

    Topics: Adult; Analysis of Variance; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Nigeria; Norgestrel; Risk Factors

1993
Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen.
    Menopause (New York, N.Y.), 1999,Summer, Volume: 6, Issue:2

    Topics: Anabolic Agents; Apolipoproteins; Cardiovascular Diseases; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Middle Aged; Norgestrel; Norpregnenes; Postmenopause; Progesterone Congeners; Treatment Outcome

1999
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
    Contraception, 1999, Volume: 60, Issue:6

    Topics: Adult; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cardiovascular Diseases; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Norgestrel; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Triglycerides

1999
Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1979, Volume: 11, Issue:7

    Topics: Adult; Cardiovascular Diseases; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Norgestrel; Phospholipids; Pregnancy; Triglycerides

1979

Other Studies

15 other study(ies) available for norgestrel and Cardiovascular Diseases

ArticleYear
Contraceptive options for women in selected circumstances.
    Best practice & research. Clinical obstetrics & gynaecology, 2010, Volume: 24, Issue:5

    Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult

2010
Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
    The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl

    Topics: Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Genital Neoplasms, Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism

1983
Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl

    Topics: Body Weight; Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism

1983
Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides.
    Maturitas, 1983, Volume: 5, Issue:2

    Topics: Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Estradiol; Estriol; Estrogens; Female; Humans; Lipoproteins, HDL; Long-Term Care; Menopause; Middle Aged; Norgestrel; Triglycerides

1983
Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
    American journal of obstetrics and gynecology, 1982, Mar-15, Volume: 142, Issue:6 Pt 2

    Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Synthetic; England; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Prospective Studies

1982
The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
    American journal of obstetrics and gynecology, 1982, Mar-15, Volume: 142, Issue:6 Pt 2

    Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides

1982
Effects of progestogens on the cardiovascular system.
    American journal of obstetrics and gynecology, 1982, Mar-15, Volume: 142, Issue:6 Pt 2

    Topics: Adult; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Coronary Disease; Estrogens; Female; Humans; Hypertension; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins

1982
Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.
    British medical journal, 1980, May-10, Volume: 280, Issue:6224

    Topics: Cardiovascular Diseases; Contraceptives, Oral; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norethindrone; Norgestrel; Thrombophlebitis

1980
Postmenopausal hormone replacement therapy and plasma lipoproteins.
    Journal of internal medicine, 1995, Volume: 238, Issue:5

    Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Progesterone Congeners; Progestins; Randomized Controlled Trials as Topic; Risk Factors

1995
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

    Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires

1995
Effect of postmenopausal estrogen replacement therapy on lipoproteins.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1996, Volume: 52, Issue:2

    Topics: Adult; Body Mass Index; Cardiovascular Diseases; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoproteins; Middle Aged; Norgestrel; Risk Factors; Time Factors

1996
Cilest (norgestimate/EE): some clinical observations.
    International journal of fertility, 1992, Volume: 37 Suppl 3

    Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Female; Glucose; Humans; Norgestrel

1992
[Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Akusherstvo i ginekologiia, 1989, Issue:7

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Chlormadinone Acetate; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease Susceptibility; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hypertension; Middle Aged; Norethindrone; Norgestrel; Risk Factors

1989
Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Contraception, 1987, Volume: 35, Issue:3

    Topics: Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Norpregnenes; Population Surveillance; Progesterone Congeners; Prospective Studies; Risk

1987
Oral contraception, 1986. Endocrinology and pharmacology. A panel discussion.
    The Journal of reproductive medicine, 1986, Volume: 31, Issue:6 Suppl

    Topics: Adult; Animals; Breast Neoplasms; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Ethinyl Estradiol; Female; Genital Neoplasms, Female; Humans; Mestranol; Middle Aged; Norethindrone; Norgestrel; Rats; Risk

1986